QP ExCELs: MultiPole Pacing (MPP) Sub-Study
1 other identifier
interventional
53
1 country
44
Brief Summary
The objective of this MultiPole Pacing (MPP) sub-study of the QP ExCELs study is to demonstrate that the MPP feature is effective by converting a percentage of cardiac resynchronization therapy (CRT) non-responders to responders. The MPP sub-study is a single-arm, multi-center, prospective trial within the ongoing QP ExCELs study (NCT02290028).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable heart-failure
Started May 2017
Typical duration for not_applicable heart-failure
44 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 15, 2017
CompletedFirst Posted
Study publicly available on registry
May 16, 2017
CompletedStudy Start
First participant enrolled
May 19, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 23, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
January 23, 2020
CompletedResults Posted
Study results publicly available
March 8, 2021
CompletedMarch 8, 2021
February 1, 2021
2.7 years
May 15, 2017
January 18, 2021
February 16, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Cardiac Resynchronization Therapy (CRT) Responder Status With the MPP Feature
Count of participants who are classified as "Improved", where responder classification is derived from a clinical composite score (CCS) based on changes in New York Heart Association (NYHA) class, Heart Failure (HF) hospitalization, and cardiovascular death. Responder classification at 6 months (evaluated compared to MPP Enrollment Visit) : * "Improved" * No HF hospitalization or cardiovascular death, AND * NYHA class is improved * "Unchanged" * No HF hospitalization or cardiovascular death, AND * NYHA class is unchanged * "Worsened" * HF hospitalization or cardiovascular death has occurred, OR * NYHA class is worsened
Enrollment to 6 Months
Secondary Outcomes (3)
Percentage of Participants Without MPP System Related Adverse Events Requiring Additional Invasive Intervention to Resolve at 6 Months.
Enrollment to 6 Months
Clinical Composite Score (CCS) + Patient Global Assessment (PGA) Responder Status Utilizing a Modified CCS That Incorporates the PGA
Enrollment to 6 Months
CCS Responder Status Utilizing an Expanded Responder Classification
Enrollment to 6 Months
Study Arms (1)
MultiPole Pacing
EXPERIMENTALTraditional biventricular pacing CRT non-responders at the 3 or 6 month QP ExCELs study follow-up.
Interventions
Eligibility Criteria
You may qualify if:
- Currently enrolled in the ongoing QP ExCELs study
- Successfully implanted with a BIOTRONIK Ilivia 7 HF-T QP family CRT-D system, or future-marketed CRT-D system with the MPP feature. Successful implantation is defined as having at least two LV pacing vectors with a measured pacing threshold of ≤ 5.0 V @ any pulse width (allowing for a minimum 2.5 V safety margin) without phrenic nerve stimulation at the final programmed pacing output at the time of enrollment into the MPP sub-study.
- CRT Responder Assessment classification as "Worsened" or "Unchanged"
- Standard continuous biventricular (BiV) pacing from implant until the 6-Month QP ExCELs follow-up visit. (Implant to 3-Month QP ExCELs follow-up who qualify due to a Heart Failure (HF) hospitalization event)
- Able to understand the nature of the sub-study and give informed consent
- Available for an additional follow-up visit specific to the MPP sub-study at the investigational site
- No evidence of non-compliance to their ongoing commitment in the QP ExCELs study
You may not qualify if:
- Have a life expectancy of less than 6 months
- Expected to receive heart transplantation or ventricular assist device within 6 months
- Chronic atrial fibrillation
- Presence of another life-threatening, underlying illness separate from their cardiac disorder
- Received MPP pacing prior to enrolment into the MPP sub-study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Biotronik, Inc.lead
Study Sites (44)
Thomas Hospital
Fairhope, Alabama, 36532, United States
South Bay Electrophysiology
Inglewood, California, 90301, United States
Eisenhower Desert Cardiology
Rancho Mirage, California, 92270, United States
MedStar Washington Hospital Center
Washington D.C., District of Columbia, 20010, United States
Florida Hospital
Orlando, Florida, 32803, United States
Orlando Health Heart Institute
Orlando, Florida, 32806, United States
Florida Hospital Tampa Pepin Heart Institute
Tampa, Florida, 33613, United States
Piedmont Heart Institute
Atlanta, Georgia, 30309, United States
University of Chicago Medical Center
Chicago, Illinois, 60637, United States
Parkview Physicians Group - Cardiology
Fort Wayne, Indiana, 46845, United States
University of Iowa Hospitals and Clinics
Iowa City, Iowa, 52242, United States
University of Kansas Hospital
Kansas City, Kansas, 66160, United States
Baptist Health - Lexington
Lexington, Kentucky, 40503, United States
University of Kentucky
Lexington, Kentucky, 40536, United States
Northeast Cardiology
Bangor, Maine, 04401, United States
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
Southcoast Health
Fall River, Massachusetts, 02720, United States
University of Massachusetts Medical School
Worcester, Massachusetts, 01655, United States
University of Michigan Hospital
Ann Arbor, Michigan, 48109, United States
Henry Ford Hospital
Detroit, Michigan, 48202, United States
Michigan Heart
Ypsilanti, Michigan, 48197, United States
Cardiology Associates of North Mississippi
Tupelo, Mississippi, 38801, United States
SSM Health St. Joseph Hospital - St. Charles
Saint Charles, Missouri, 63301, United States
Mercy Clinic Cardiology
Springfield, Missouri, 65804, United States
St. Louis Heart and Vascular
St Louis, Missouri, 63136, United States
Glacier View Medical Research Institute, Cardiology
Kalispell, Montana, 59901, United States
Jersey Shore University Medical Center
Neptune City, New Jersey, 07753, United States
New York Presbyterian Queens
Flushing, New York, 11355, United States
Weill Cornell Medicine
New York, New York, 10021, United States
Mt. Sinai St. Luke's Hospital
New York, New York, 10025, United States
Montefiore Medical Center
The Bronx, New York, 10467, United States
Westchester Medical Center
Valhalla, New York, 10595, United States
Asheville Cardiology Associates
Asheville, North Carolina, 28803, United States
Novant Health Winston-Salem Cardiology
Winston-Salem, North Carolina, 27103, United States
Wake Forest Baptist Health Medical Center
Winston-Salem, North Carolina, 27157, United States
Sanford Medical Center - Fargo
Fargo, North Dakota, 58102, United States
University of Cincinnati
Cincinnati, Ohio, 45219, United States
Temple Heart and Vascular Institute
Philadelphia, Pennsylvania, 19140, United States
Upstate Cardiology
Greenville, South Carolina, 29607, United States
UT Erlanger Cardiology
Chattanooga, Tennessee, 37403, United States
Fort Worth Heart
Fort Worth, Texas, 76104, United States
UT Health Science Center
The Woodlands, Texas, 77380, United States
University of Utah Medical Center
Salt Lake City, Utah, 84132, United States
UVM Medical
Burlington, Vermont, 05401, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Clinical Studies Engineer Manager
- Organization
- BIOTRONIK
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 15, 2017
First Posted
May 16, 2017
Study Start
May 19, 2017
Primary Completion
January 23, 2020
Study Completion
January 23, 2020
Last Updated
March 8, 2021
Results First Posted
March 8, 2021
Record last verified: 2021-02